No Data
No Data
ICAD, Inc. Announces Presentation of Four Novel AI-Driven Breast Cancer Research Abstracts at 2024 San Antonio Breast Cancer Symposium
SABCS 2024: New Research Assesses ICAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations
Express News | ICAD Advances Fight Against Breast Cancer With FDA-Cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at Rsna 2024
ICAD Advances Fight Against Breast Cancer With FDA-cleared, Next-Generation AI Solutions and a Second-Read AI Partnership With Cascaid Health at RSNA 2024
Colliers Securities Initiates ICAD Inc(ICAD.US) With Buy Rating, Announces Target Price $3
Need To Know: Analysts Just Made A Substantial Cut To Their ICAD, Inc. (NASDAQ:ICAD) Estimates
Unlock the Full List